Auri
AURI · OTC
About AURI
- Employees
- 3
- Headquarters
- Chapel Hill, North Carolina
- Listed
- Apr 17, 2003
- Sector
- Consumer Discretionary
- Industry
- Textiles, Apparel & Luxury Goods
AURI key statistics
- Market cap
- 915.88K
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 23.87M
- Volume
- 353.00K
- Open price
- $0.0001
- High today
- $0.0001
- Low today
- $0.00
- 52 Week high
- $0.0006
- 52 Week low
- $0.00
Auri (AURI) at a glance
Auri (AURI) last traded at $0.0001, with a market cap of 915.88K and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.00 and $0.0001. The current price is — above the day's low and 0.0% below its high.
Volume so far is 353.00K shares, below the average of 23.87M shares a day.
Over the past year Auri has ranged from $0.00 to $0.0006, and now sits 17% of the way up that range.
AURI news
- Press releaseACCESSWIRE
Similar companies
Companies in the same industry as Auri
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.